Mattson Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.14M Sell
3,231
-85
-3% -$30.3K 0.27% 105
2025
Q4
$1.09M Sell
3,316
-1
-0% -$317 0.25% 105
2025
Q3
$936K Buy
3,317
+28
+0.9% +$8.12K 0.22% 116
2025
Q2
$918K Buy
3,289
+42
+1% +$11.9K 0.25% 112
2025
Q1
$1.01M Buy
3,247
+463
+17% +$137K 0.3% 96
2024
Q4
$897K Sell
2,784
-1,194
-30% -$354K 0.29% 111
2024
Q3
$1.24M Sell
3,978
-27
-0.7% -$8.83K 0.45% 78
2024
Q2
$1.25M Buy
+4,005
New +$1.18M 0.45% 78

Other funds holding AMGN

Mattson Financial Services's AMGN Position: Q1 2026 in Review

Mattson Financial Services reduced its Amgen (AMGN) stake by 2.6% in Q1 2026, selling an estimated $30.3K and leaving 3,231 shares worth $1.14M. The position accounts for 0.27% of the portfolio, ranked #105.

Mattson Financial Services first reported a position in AMGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.25M in Q2 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Mattson Financial Services held 3,231 shares of Amgen worth $1.14M as of Q1 2026.
  • Mattson Financial Services sold 85 Amgen shares in Q1 2026, an estimated $30.3K.
  • Amgen made up 0.27% of Mattson Financial Services's portfolio in Q1 2026, its #105 holding.
  • Mattson Financial Services first reported a position in Amgen in Q2 2024 and has held it in 8 quarters since.
  • Mattson Financial Services's Amgen position peaked at $1.25M in Q2 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Mattson Financial Services's 13F filing for Q1 2026, filed 11 May 2026.